Pettiti Gianluca

Pettiti Gianluca, an Executive Vice President, has demonstrated a clear selling bias in recent insider transactions, primarily involving Thermo Fisher Scientific (TMO) and a single filing for HP Inc. (HPQ). Over 33 reported trades, Gianluca has sold $5.28 million worth of shares compared to $845,687 in buys, with no recent purchases recorded. The most recent activity includes five sales in 2026, including a $172,842 transaction and a $386,513 disposition on February 28, following a $216,480 sale on February 9. Prior to this, Gianluca executed larger sales in late 2025, including a $1.31 million transaction on November 10 alongside derivative dispositions totaling $845,688. The pattern shows concentrated activity in TMO, with no meaningful buys since August 2025, when Gianluca acquired shares in smaller increments, such as four purchases around $73,168–$124,077 each. The HPQ filing from February 2025 was an acquisition with no reported value, suggesting it may have been an award or grant. The absence of recent buys and the repeated sales—particularly the multi-million-dollar dispositions in late 2025—indicate a sustained reduction in Gianluca’s TMO holdings. The transactions are spread across open-market sales (code S), derivative exercises (M), and other financial transactions (F), with no new equity awards (code A) of material value since early 2025.